Abstract Heart failure is a chronic disease, the symptoms of which occur due to a lack of cardiac output. It can be better managed with continuous and real time monitoring. Some efforts have been made in the past for the management of heart failure. Most of these efforts were based on a single parameter for example thoracic impedance or heart rate alone. Herein, we report a wearable device that can provide monitoring of multiple physiological parameters related to heart failure. It is based on the sensing of multiple parameters simultaneously including thoracic impedance, heart rate, electrocardiogram and motion activity. These parameters are measured using different sensors which are embedded in a wearable belt for their continuous and real time monitoring. The healthcare wearable device has been tested in different conditions including sitting, standing, laying, and walking. Results demonstrate that the reported wearable device keeps track of the aforementioned parameters in all conditions.
more »
« less
A Wearable Internet of Things Device for Noninvasive Remote Monitoring of Vital Signs Related to Heart Failure
Cardiovascular disease is one of the leading causes of death in the world. Heart failure is a cardiovascular disease in which the heart is unable to pump sufficient blood to fulfill the body’s requirements and can lead to fluid overload. Traditional solutions are not adequate to address the progression of heart failure. Herein, we report a body-mounted wearable sensor to monitor the parameters related to heart failure. These include heart rate, blood oxygen saturation, thoracic impedance, and activity status. The device is compact and wearable and measures the parameters continuously in real time. The device is an Internet of Things (IoT) device connected with a cloud-based database enabling the parameters to be visualized on a mobile application.
more »
« less
- Award ID(s):
- 1942487
- PAR ID:
- 10535317
- Publisher / Repository:
- MDPI
- Date Published:
- Journal Name:
- IoT
- Volume:
- 5
- Issue:
- 1
- ISSN:
- 2624-831X
- Page Range / eLocation ID:
- 155 to 167
- Format(s):
- Medium: X
- Sponsoring Org:
- National Science Foundation
More Like this
-
-
Cardiovascular diseases are a leading cause of death worldwide. They mainly include coronary artery disease, rheumatic heart disease, andcerebrovascular disease, and. Cardiovascular diseases can be better managed and diagnosed using wearable devices. Wearable devices, in comparison to traditional cardiovascular diagnostic tools, are not only inexpensive but also have the potential to provide continuous real-time monitoring. This paper reviews some of the recent advances in cardiovascular wearable devices. It discusses traditional implantable devices for cardiovascular diseases as well as wearable devices. The different types of wearable devices are categorized based on different technologies, namely using galvanic contact, photoplethysmography (PPG), and radio frequency (RF) waves. It also highlights the use of artificial intelligence (AI) in cardiovascular disease diagnostics as well as future perspectives on cardiovascular devices.more » « less
-
Left ventricular assist devices (LVADs) have been used for end-stage heart failure patients as a therapeutic option. The aortic valve plays a critical role in heart failure and its treatment with a LVAD. The cardiovascular-LVAD model is often used to investigate the physiological demands required by patients and predict the hemodynamic of the native heart supported with a LVAD. As it is a “ bridge-to-recovery ” treatment, it is important to maintain appropriate and active dynamics of the aortic valve and the cardiac output of the native heart, which requires that the LVAD pump be adjusted so that a proper balance between the blood contributed through the aortic valve and the pump is maintained. In this paper, we investigate how the pump power of the LVAD pump can affect the dynamic behaviors of the aortic valve for different levels of activity and different severities of heart failure. Our objective is to identify a critical value of the pump power (i.e., breakpoint ) to ensure that the LVAD pump does not take over the pumping function in the cardiovascular-pump system and share the ejected blood with the left ventricle to help the heart to recover. In addition, the hemodynamic often involves variability due to patients’ heterogeneity and the stochastic nature of the cardiovascular system. The variability poses significant challenges to understanding dynamic behaviors of the aortic valve and cardiac output. A generalized polynomial chaos (gPC) expansion is used in this work to develop a stochastic cardiovascular-pump model for efficient uncertainty propagation, from which it is possible to rapidly calculate the variance in the aortic valve opening duration and the cardiac output in the presence of variability. The simulation results show that the gPC-based cardiovascular-pump model is a reliable platform that can provide useful information to understand the effect of the LVAD pump on the hemodynamic of the heart.more » « less
-
In the United States, heart disease is the leading cause of death, killing about 695,000 people each year. Myocardial infarction (MI) is a cardiac complication which occurs when blood flow to a portion of the heart decreases or halts, leading to damage in the heart muscle. Heart failure and Atrial fibrillation (AF) are closely associated with MI. Heart failure is a common complication of MI and a risk factor for AF. Machine learning (ML) and deep learning techniques have shown potential in predicting cardiovascular conditions. However, developing a sim- plified predictive model, along with a thorough feature analysis, is challenging due to various factors, including lifestyle, age, family history, medical conditions, and clinical variables for cardiac complications prediction. This paper aims to develop simplified models with comprehensive feature analysis and data preprocessing for predicting cardiac complications, such as heart failure and atrial fibrillation linked with MI, using a publicly available dataset of myocardial infarction patients. This will help the students and health care professionals understand various factors responsible for cardiac complications through a simplified workflow. By prioritizing interpretability, this paper illustrates how simpler models, like decision trees and logistic regression, can provide transparent decision-making processes while still maintaining a balance with accuracy. Additionally, this paper examines how age-specific factors affect heart failure and atrial fibrillation conditions. Overall this research focuses on making machine learning accessible and interpretable. Its goal is to equip students and non-experts with practical tools to understand how ML can be applied in healthcare, particularly for the cardiac complications prediction for patients having MI.more » « less
-
Alterations in microvasculature represent some of the earliest pathological processes across a wide variety of human diseases. In many organs, however, inaccessibility and difficulty in directly imaging tissues prevent the assessment of microvascular changes, thereby significantly limiting their translation into improved patient care. The eye provides a unique solution by allowing for the non-invasive and direct visualization and quantification of many aspects of the human microvasculature, including biomarkers for structure, function, hemodynamics, and metabolism. Optical coherence tomography angiography (OCTA) studies have specifically identified reduced capillary densities at the level of the retina in several eye diseases including glaucoma. This narrative review examines the published data related to OCTA-assessed microvasculature biomarkers and major systemic cardiovascular disease. While loss of capillaries is being established in various ocular disease, pilot data suggest that changes in the retinal microvasculature, especially within the macula, may also reflect small vessel damage occurring in other organs resulting from cardiovascular disease. Current evidence suggests retinal microvascular biomarkers as potential indicators of major systemic cardiovascular diseases, including systemic arterial hypertension, atherosclerotic disease, and congestive heart failure.more » « less
An official website of the United States government

